1型糖尿病患者骨折的直接医疗费用:丹麦一项基于人群的队列研究
该研究基于丹麦国家患者登记系统,比较2011-2019年1型糖尿病(T1D)患者与匹配的非糖尿病对照在髋部、肱骨、前臂、足部和踝部骨折后第一年的直接医疗费用。T1D患者肱骨、前臂、足部和踝部骨折后1年直接医疗费用显著高于对照,而髋部骨折费用两组相似。髋部骨折费用最高,但两组无差异。
要点
- T1D患者肱骨、前臂、足部和踝部骨折后1年直接医疗费用显著高于非糖尿病对照。
- T1D患者髋部骨折后1年直接医疗费用与对照相似(€9463 vs €9429)。
- 髋部骨折是最昂贵的骨折部位,但T1D与对照间1年费用无差异。
核心结论
- 髋部骨折是最昂贵的骨折部位,但T1D患者与对照的骨折后1年直接医疗费用无差异;其他所有骨折部位T1D患者费用显著更高。
- 作者认为,提高T1D患者骨折预防策略的采纳可能有助于降低骨折风险及后续费用。
研究设计与样本
- 基于丹麦国家患者登记系统的基于人群的队列研究,纳入2011-2019年髋部、肱骨、前臂、足部和踝部骨折患者。
- T1D患者按1:4与非糖尿病对照匹配,计算骨折后第一年住院、初级保健医生、物理治疗和药物费用。
主要发现
- T1D患者中识别出髋部骨折973例、肱骨骨折622例、前臂骨折1144例、足部骨折945例、踝部骨折472例。
- 骨折后1年直接医疗费用T1D患者 vs 非糖尿病对照:肱骨€726 vs €562,前臂€441 vs €269,足部€225 vs €123,踝部€551 vs €367,上述部位T1D患者费用显著更高。
- 髋部骨折后1年直接医疗费用T1D患者 vs 对照:€9463 vs €9429,两组相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Patients with type 1 diabetes (T1D) have increased risk of post-fracture complications, such as impaired healing and surgical complications compared to patients without diabetes. However, it is not known if this translates to higher healthcare costs. OBJECTIVE: We aimed to compare the direct healthcare costs within the first year of hip, humerus, forearm, foot, and ankle fractures between patients with T1D and matched controls. METHODS: Patients with hip, humerus, forearm, foot, and ankle fractures in the period 2011-2019 were identified from the Danish National Patient Register. Patients with T1D were matched 1:4 with patients without diabetes. Costs for hospitalizations, primary care physicians, physiotherapy, and medication within the first year after a fracture were calculated. RESULTS: We identified 973 hip, 622 humerus, 1144 forearm, 945 foot, and 472 ankle fractures in patients with T1D. The direct healthcare cost within 1 year after fracture was significantly higher among patients with T1D compared to patients without diabetes for humerus (€726 vs €562), forearm (€441 vs €269), foot (€225 vs €123), and ankle fractures (€551 vs €367). By contrast, the direct healthcare cost of hip fractures was similar in patients with T1D and controls (€9463 vs €9429). CONCLUSION: While hip fractures were the most costly site, there were no differences in the 1-year post-fracture direct healthcare costs. However, the costs were significantly higher at all other fracture sites among patients with T1D. Increased uptake of fracture prevention strategies among T1D may help reduce fracture risk and subsequently costs.
引用
- Kvist AV, Frost M, Burden AM, et al. Direct Healthcare Cost of Fractures in Patients With Type 1 Diabetes: A Population-Based Cohort Study in Denmark. J Clin Endocrinol Metab. 2025. PMID: 40205723. doi:10.1210/clinem/dgaf199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。